FI871568A - Arylsubstituerade naftyridin- och pyridopyrazinderivat. - Google Patents

Arylsubstituerade naftyridin- och pyridopyrazinderivat. Download PDF

Info

Publication number
FI871568A
FI871568A FI871568A FI871568A FI871568A FI 871568 A FI871568 A FI 871568A FI 871568 A FI871568 A FI 871568A FI 871568 A FI871568 A FI 871568A FI 871568 A FI871568 A FI 871568A
Authority
FI
Finland
Prior art keywords
pyridopyrazinderivat
arylsubstituerade
naftyridin
och
disclosed
Prior art date
Application number
FI871568A
Other languages
English (en)
Other versions
FI88033B (fi
FI871568A0 (fi
FI88033C (fi
Inventor
David John Blythin
Ho-Jane Shue
Marvin Ira Siegel
Sidney Randall Smith
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/921,288 external-priority patent/US4882332A/en
Application filed by Schering Corp filed Critical Schering Corp
Publication of FI871568A0 publication Critical patent/FI871568A0/fi
Publication of FI871568A publication Critical patent/FI871568A/fi
Publication of FI88033B publication Critical patent/FI88033B/fi
Application granted granted Critical
Publication of FI88033C publication Critical patent/FI88033C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FI871568A 1986-04-11 1987-04-09 Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklobuta-, cyklopenta- och 7,8,9,10-tetrahydrobenso/c//1,8/naftyridin-6-onderivat FI88033C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US85106886A 1986-04-11 1986-04-11
US85106886 1986-04-11
US06/921,288 US4882332A (en) 1986-10-20 1986-10-20 Immune suppression method employing arly-substituted naphthyridine and pyridopyrazine derivatives
US92128886 1986-10-20

Publications (4)

Publication Number Publication Date
FI871568A0 FI871568A0 (fi) 1987-04-09
FI871568A true FI871568A (fi) 1987-10-12
FI88033B FI88033B (fi) 1992-12-15
FI88033C FI88033C (fi) 1993-03-25

Family

ID=27126973

Family Applications (1)

Application Number Title Priority Date Filing Date
FI871568A FI88033C (fi) 1986-04-11 1987-04-09 Foerfarande foer framstaellning av farmakologiskt vaerdefulla cyklobuta-, cyklopenta- och 7,8,9,10-tetrahydrobenso/c//1,8/naftyridin-6-onderivat

Country Status (16)

Country Link
EP (1) EP0241291B1 (fi)
JP (1) JPH0774215B2 (fi)
KR (1) KR870010049A (fi)
AT (1) ATE90096T1 (fi)
AU (1) AU609389B2 (fi)
CA (1) CA1324381C (fi)
DE (1) DE3786036T2 (fi)
DK (1) DK186487A (fi)
ES (1) ES2054665T3 (fi)
FI (1) FI88033C (fi)
HU (1) HU200768B (fi)
IL (1) IL82150A0 (fi)
NO (1) NO165923C (fi)
NZ (1) NZ219931A (fi)
OA (1) OA08583A (fi)
PT (1) PT84658B (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
US5037826A (en) * 1986-10-15 1991-08-06 Schering Corporation 1-substituted naphthyridine and pyridopyrazine derivatives
AU2009333653B2 (en) * 2008-12-17 2015-09-10 Merck Patent Gmbh C-ring modified tricyclic benzonaphthiridinone protein kinase inhibitors and use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4680298A (en) * 1983-05-31 1987-07-14 Schering Corporation Tricyclic anti-allergy and use as anti-inflammatory agents
DE3481418D1 (de) * 1983-12-14 1990-04-05 Schering Corp Substituierte spiropyridinderivate, diese enthaltende pharmazeutische zubereitungen, verfahren zu ihrer herstellung und zubereitungen.
DK127086A (da) * 1985-03-25 1986-09-26 Schering Corp Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
US4596809A (en) * 1985-03-25 1986-06-24 Schering Corporation Substituted 1,8-naphthyridinones, useful as anti-allergic agents

Also Published As

Publication number Publication date
JPS62270582A (ja) 1987-11-24
PT84658A (en) 1987-05-01
DK186487D0 (da) 1987-04-10
FI88033B (fi) 1992-12-15
IL82150A0 (en) 1987-10-30
JPH0774215B2 (ja) 1995-08-09
NO871507D0 (no) 1987-04-10
KR870010049A (ko) 1987-11-30
OA08583A (fr) 1988-09-30
ES2054665T3 (es) 1994-08-16
DK186487A (da) 1987-10-12
DE3786036T2 (de) 1993-09-09
NZ219931A (en) 1989-10-27
EP0241291A2 (en) 1987-10-14
HUT43847A (en) 1987-12-28
AU7135887A (en) 1987-10-15
CA1324381C (en) 1993-11-16
AU609389B2 (en) 1991-05-02
PT84658B (pt) 1989-11-30
EP0241291B1 (en) 1993-06-02
FI871568A0 (fi) 1987-04-09
FI88033C (fi) 1993-03-25
NO165923C (no) 1991-05-02
DE3786036D1 (de) 1993-07-08
EP0241291A3 (en) 1989-05-31
NO165923B (no) 1991-01-21
NO871507L (no) 1987-10-12
HU200768B (en) 1990-08-28
ATE90096T1 (de) 1993-06-15

Similar Documents

Publication Publication Date Title
EP0335901A4 (en) Methods and compositions for the treatment of non-ige-mediated diseases
ATE79544T1 (de) Zusammensetzungen zur behandlung von hypercholesterinaemie.
DE3752007D1 (de) Mittel zur Entziehung von Endprodukten der fortgeschrittenen Glycosylation
MX9307886A (es) Composicion farmaceutica y proceso para su preparacion.
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
FI871568A0 (fi) Arylsubstituerade naftyridin- och pyridopyrazinderivat.
NZ216519A (en) Polycyclic compounds and pharmaceutical compositions
MY100071A (en) Aryl-substituted naphthyridine and pyridopyrazine derivatives
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
GR75239B (fi)
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
ATE73645T1 (de) Mittel zur behandlung von alopezien.

Legal Events

Date Code Title Description
MM Patent lapsed
FD Application lapsed
MM Patent lapsed

Owner name: SCHERING CORPORATION